Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia.
Fujita Y, Kinoshita M, Furukawa Y, Nagano T, Hashimoto H, Hirami Y, Kurimoto Y, Arakawa K, Yamazaki K, Okada Y, Katakami N, Uno E, Matsubara Y, Fukushima M, Nada A, Losordo DW, Asahara T, Okita Y, Kawamoto A.
Fujita Y, et al.
Circ J. 2014;78(2):490-501. doi: 10.1253/circj.cj-13-0864. Epub 2013 Nov 21.
Circ J. 2014.
PMID: 24257136
Free article.
Clinical Trial.